Human aflatoxin B1 aldehyde reductase

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435190, C12Q 168, C12N 1509

Patent

active

060717041

ABSTRACT:
The invention provides a human aflatoxin B1 aldehyde reductase (AFB1-hAR) and polynucleotides which identify and encode AFB1-hAR. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating disorders associated with expression of AFB1-hAR.

REFERENCES:
patent: 5795761 (1998-08-01), Powers et al.
Hayes, J.D., et al., "Resistance to Aflatoxin B1 Is Associated with the Expression of a Novel Aldo-Keto Reductase Which Has Catalytic Activity Towards a Cytotoxic Aldehyde-containing Metabolite of the Toxin", Cancer Research, 53:3887-3894 (1993).
Judah, D.J., et al., "A novel aldehyde reductase with activity towards a metabolite of aflatoxin B1 is expressed in rat liver during carcinogenesis and following the administration of an anti-oxidant", Biochem J, 292:13-18 (1993).
Ellis, E.M., et al., "An ethoxyquin-inducible aldehyde reductase from rat liver that metabolizes aflatoxin B.sub.1 defines a subfamily of aldo-keto reductases", Proc Natl Acad Sci, USA, 90:10350-10354 (1993). (GI 433610) (GI 433611).
McGlynn, K.A., et al., "Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B.sub.1 ", Proc Natl Acad Sci, USA, 92:2384-2387 (1995).
Aguilar, F., et al., "Aflatoxin B.sub.1 induces the transversion of G.fwdarw. T in codon 249 of the p53 tumor suppressor gene in human hepatocytes", Proc Natl Acad Sci USA, 90:8586-8590 (1993).
Ellis, E.M., (GI 433611) GenBank Sequence Database (Accession X74673), National Center for Biotechnology Information: National Library of Medicine, Bethesda, Maryland 20849 Dec. 7, 1993.
Ellis, E.M., (GI 433610) GenBank Sequence Database (Accession X74673), National Center for Biotechnology Information: National Library of Medicine, Bethesda, Maryland 20849 Dec. 7, 1993.
Wang, A. et al., "Cloning, Expression, and Catalytic Mechanism of Murine Lysophospholipase I", J. Biol. Chem., May 9, 1997, 272(19) 12723-12729.
Genbank Accession Q60770, "Human brain Expressed Sequence Tag EST00883", Submitted by Adams et al. Mar. 16. 1994.
Wells et al., "Additivity of mutational effects in proteins", Biochemistry 29(37): 8509-8517 (1990).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Human aflatoxin B1 aldehyde reductase does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Human aflatoxin B1 aldehyde reductase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human aflatoxin B1 aldehyde reductase will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2212074

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.